Cell-of-origin chromatin organization shapes the mutational landscape of cancer
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
An analysis of cell-type-specific epigenomic features reveals a relationship between epigenomic and mutational profiles; chromatin characteristics can explain a large proportion of mutational variance in cancer genomes and the mutational distribution can identify the probable cell type from which a given cancer originated from. Genomic studies have shown that different cancer types vary substantially in the local density and types of somatic mutations. This has been explained not only by differences in DNA sequence but also by other features including epigenetic organization. Shamil Sunyaev and colleague now compare mutation densities to detailed epigenetic profiles of different cell types and tissues. They demonstrate that epigenomic features of a given cell type or tissue in which a cancer arises are much stronger determinants of mutational profiles than other properties. Conversely, the findings make it possible to deduce information on the possible tissue-of-origin of a tumour based on its mutational landscape. Cancer is a disease potentiated by mutations in somatic cells. Cancer mutations are not distributed uniformly along the human genome. Instead, different human genomic regions vary by up to fivefold in the local density of cancer somatic mutations1, posing a fundamental problem for statistical methods used in cancer genomics. Epigenomic organization has been proposed as a major determinant of the cancer mutational landscape1,2,3,4,5. However, both somatic mutagenesis and epigenomic features are highly cell-type-specific6,7. We investigated the distribution of mutations in multiple independent samples of diverse cancer types and compared them to cell-type-specific epigenomic features. Here we show that chromatin accessibility and modification, together with replication timing, explain up to 86% of the variance in mutation rates along cancer genomes. The best predictors of local somatic mutation density are epigenomic features derived from the most likely cell type of origin of the corresponding malignancy. Moreover, we find that cell-of-origin chromatin features are much stronger determinants of cancer mutation profiles than chromatin features of matched cancer cell lines. Furthermore, we show that the cell type of origin of a cancer can be accurately determined based on the distribution of mutations along its genome. Thus, the DNA sequence of a cancer genome encompasses a wealth of information about the identity and epigenomic features of its cell of origin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutation rates vary in different parts of the genome, at different stages of the life cycle and in diseases such as cancer, where they depend on the cell of origin, environmental exposure and cancer type [60][61][62] .”
From Advances in epigenetics link genetics to the environment and disease (2019) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Integrative analysis of 111 reference human epigenomes
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. (2015) · Nature · doi:10.1038/nature14248 · Cited by 6,368
Self-citationMutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Self-citationThe Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E. S., & Getz, G. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,981
Self-citationComprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Self-citationPermutation importance: a corrected feature importance measure
Altmann, A., Toloşi, L., Sander, O., & Lengauer, T. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq134 · Cited by 2,843
The accessible chromatin landscape of the human genome
Thurman, R. E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M. T., Haugen, E., Sheffield, N. C., Stergachis, A. B., Wang, H., Vernot, B., et al. (2012) · Nature · doi:10.1038/nature11232 · Cited by 2,679
Self-citation
Cited by
Items 201–300 of 548
Genomic diversity landscapes in outcrossing and selfing Caenorhabditis nematodes
Teterina, A. A., Willis, J. H., Lukac, M., Jovelin, R., Cutter, A. D., & Phillips, P. C. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010879 · Cited by 43
Criticality in tumor evolution and clinical outcome
Persi, E., Wolf, Y. I., Leiserson, M. D. M., Koonin, E. V., & Ruppin, E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807256115 · Cited by 40
“Our findings are also consistent with the observation that both genetic and epigenetic characteristics of the original normal cell are key determinants of the mutational spectrum of the respective cancer cell (56).”
Replication Stress, Genomic Instability, and Replication Timing: A Complex Relationship
Briu, L.-M., Maric, C. A., & Cadoret, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094764 · Cited by 40
Goldberg, M. E., & Harris, K. (2021) · Genome Biology and Evolution · doi:10.1093/gbe/evab104 · Cited by 41
“…the genome accumulate mutations faster than others, such as DNA that replicates late in the cell cycle and motifs with certain epigenetic modifications (Stamatoyannopoulos et al. 2009; Koren et al. 2012; Schuster-Böckler and Lehner 2012; Liu et al. 2013; Sima and Gilbert 2014; Polak et al. 2015).”
BackgroundChromatin structure–based prediction of recurrent noncoding mutations in cancer
Kim, K., Jang, K., Yang, W., Choi, E.-Y., Park, S.-M., Bae, M., Kim, Y., & Choi, J. K. (2016) · Nature Genetics · doi:10.1038/ng.3682 · Cited by 36
Zuber, V., GWAS, T. C., Bettella, F., Witoelar, A., Andreassen, O. A., Mills, I. G., & Urbanucci, A. (2017) · BMC Genomics · doi:10.1186/s12864-017-3620-y · Cited by 39
“This is a concept that has recently been postulated for cancer mutations occurring in a chromatin-specific context [40].”
BackgroundNuclear topology modulates the mutational landscapes of cancer genomes
Smith, K. S., Liu, L. L., Ganesan, S., Michor, F., & De, S. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3474 · Cited by 33
Somatic structural variant formation is guided by and influences genome architecture
Sidiropoulos, N., Mardin, B. R., Rodríguez-González, F. G., Bochkov, I. D., Garg, S., Stütz, A. M., Korbel, J. O., Aiden, E. L., & Weischenfeldt, J. (2022) · Genome Research · doi:10.1101/gr.275790.121 · Cited by 34
Sasaki, T., Rivera‐Mulia, J. C., Vera, D. L., Zimmerman, J., Das, S., Padget, M. R., Nakamichi, N., Chang, B. H., Tyner, J. W., Druker, B. J., et al. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.04.004 · Cited by 30
“…DNA that are replicated during late versus early S-phase, knowledge of RT in patient samples aids the distinction of driver and passenger mutations (Lawrence et al., 2013; Lochovsky et al.; Polak et al., 2015; Shugay et al., 2012; Sima and Gilbert, 2014; Supek and Lehner, 2015; Woo and Li, 2012).”
BackgroundIntraspecific Diversity of Fission Yeast Mitochondrial Genomes
Tao, Y., Suo, F., Tusso, S., Wang, Y., Huang, S. M., Wolf, J. B. W., & Du, L. (2019) · Genome Biology and Evolution · doi:10.1093/gbe/evz165 · Cited by 32
Identifying co‐opted transposable elements using comparative epigenomics
Venuto, D., & Bourque, G. (2018) · Development Growth & Differentiation · doi:10.1111/dgd.12423 · Cited by 34
“Rates here are more challenging to estimate given the rapid evolution of noncoding DNA vs. protein coding DNA and the problems in selecting good unbiased reference sites (Gaffney & Keightley 2006; Pollard et al. 2006).”
BackgroundNew insights into the neurofibroma tumor cells of origin
Li, S., Chen, Z., & Le, L. Q. (2019) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdz044 · Cited by 40
DNA polymerase zeta contributes to heterochromatin replication to prevent genome instability
Yamin, B. B., Ahmed‐Seghir, S., Tomida, J., Despras, E., Pouvelle, C., Yurchenko, A. A., Goulas, J., Corre, R., Delacour, Q., Droin, N. M., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020104543 · Cited by 35
“…that replication timing influences genomic mutation rates with an increasing gradient of single-nucleotide substitutions that correlate with late-replicating regions (Stamatoyannopoulos et al , 2009; Koren et al , 2012; Polak et al , 2015), but the causative underlying mechanisms remain elusive.”
Mitigating age-related somatic mutation burden
Vijg, J., Schumacher, B., Abakir, A., Antonov, M., Bradley, C., Cagan, A., Church, G. M., Gladyshev, V. N., Gorbunova, V. A., Maslov, A. Y., et al. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.04.002 · Cited by 33
“Since a sizeable number of somatic mutations originate in well-defined chromatin regions [57], and chromatin organization is a major influencer of the mutation landscape [58], it might be possible to protect sites from turning into mutation hotspots through local chromatin engineering.”
Sanjaya, P., Maljanen, K., Katainen, R., Waszak, S. M., Ambrose, J. C., Arumugam, P., Bevers, R. P. J., Bleda, M., Boardman-Pretty, F., Boustred, C., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01204-4 · Cited by 35
“Our method, MuAt, can be extended to incorporate additional data on somatic mutations, such as epigenetics, potentially enabling scrutiny of the role of epigenetic interactions in somatic mutagenesis [59, 60, 61, 13, 62].”
MethodRetrieval of Leaf Area Index Using Sentinel-2 Imagery in a Mixed Mediterranean Forest Area
Chrysafis, I., Korakis, G., Kyriazopoulos, A. P., & Mallinis, G. (2020) · ISPRS International Journal of Geo-Information · doi:10.3390/ijgi9110622 · Cited by 29
“Using backward eli ination selection tech ique [49] and gradually removing the l ast contr buting variables, we est lishe an adequate set of features as input for the new models.”
MethodChaperoning histones at the DNA repair dance
Chakraborty, U., Shen, Z.-J., & Tyler, J. K. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103240 · Cited by 33
“Closed chromatin regions, which usually are repaired less efficiently by NER, are associated with high somatic mutations in melanomas while lower mutation density is found in accessible chromatin regions, indicating that accessibility to the NER machinery is generally reduced by the closed chromatin state, independent…”
BackgroundCao, Y. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0406-y · Cited by 31
Jiang, L., Zheng, J., Kwan, J. S. H., Dai, S., Li, C., Li, M. J., Yu, B., TO, K. F., Sham, P. C., Zhu, Y., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz566 · Cited by 35
“suggested cell-of-origin chromatin features (including chromatin accessibility) were stronger determinants of cancer mutation profiles of the entire genome than chromatin features of matched cancer cell lines (15).”
BackgroundChromatin structure influences rate and spectrum of spontaneous mutations in Neurospora crassa
de la Peña, M. V., Summanen, P. A. M., Liukkonen, M., & Kronholm, I. (2023) · Genome Research · doi:10.1101/gr.276992.122 · Cited by 36
“DELLY 0.8.7 (Rausch et al. 2012) and Lumpy 0.2.13 (Layer et al. 2014) were the callers that performed best, and they were selectedforgenotyping.”
InfluentialDeterminants and role of chromatin organization in acute leukemia
Fang, C., Rao, S., Crispino, J. D., & Ntziachristos, P. (2020) · Leukemia · doi:10.1038/s41375-020-0981-z · Cited by 37
“Accessibility signatures of cancers have been shown to predict mutational signatures [134] and distinguish leukemia cells of origin in a model of AML driven by the MLL-AF9 fusion oncogene [135].”
BackgroundLiquid biopsy in urothelial carcinoma: Detection techniques and clinical applications
Wu, S., Li, R., Jiang, Y., Yu, J., Zheng, J., Li, Z., Li, M., Xin, K., Wang, Y., Xu, Z., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115027 · Cited by 33
Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia
Basilico, S., & Göttgens, B. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1535-3 · Cited by 31
“Finally, exciting studies have also provided a definition of the leukaemia cell of origin based on the chromatin landscape, which represents a powerful platform for the identification of new epigenetic biomarkers [55, 56].”
BackgroundDhingra, P., Martinez‐Fundichely, A., Berger, A., Huang, F. W., Forbes, A. N., Liu, E. M., Liu, D., Sboner, A., Tamayo, P., Rickman, D. S., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1266-3 · Cited by 30
“The null background is computed from random combinations of an equal number of SNVs in the element [68, 69] (Methods).”
MethodSingle-cell multi-omics map of human fetal blood in Down syndrome
Marderstein, A. R., De Zuani, M., Moeller, R., Bezney, J., Padhi, E. M., Wong, S., Coorens, T. H. H., Xie, Y., Xue, H., Montgomery, S. B., et al. (2024) · Nature · doi:10.1038/s41586-024-07946-4 · Cited by 26
“13–15 and Supplementary Notes 9–14).”
Jikuya, R., Johnson, T. A., Maejima, K., An, J., Ju, Y.-S., Lee, H., Ha, K., Song, W., Kim, Y.-W., Okawa, Y., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104596 · Cited by 27
Replication timing and nuclear structure
Fu, H., Baris, A. M., & Aladjem, M. I. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.01.004 · Cited by 26
Pioneer Factors and Architectural Proteins Mediating Embryonic Expression Signatures in Cancer
Dobersch, S., Rubio, K., & Barreto, G. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.01.008 · Cited by 28
Niculescu, V. F. (2019) · Gene · doi:10.1016/j.gene.2019.144174 · Cited by 28
MIAOME: Human microbiome affect the host epigenome
Wang, L., Zhang, W., Wu, X., Xiao, L., Cao, L., Zhai, J., Yang, Y., Chen, Q., Liu, H., Zhang, J., et al. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.05.024 · Cited by 25
“The epigenome is highly cell-type-specific [70,71].”
Recurrent somatic mutations reveal new insights into consequences of mutagenic processes in cancer
Stobbe, M. D., Thun, G. A., Diéguez-Docampo, A., Oliva, M., Whalley, J. P., Raineri, E., & Gut, I. G. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007496 · Cited by 29
“For instance, mutation rate is influenced by replication time [8], is linked to epigenomic features [9], shows a periodic pattern around nucleosomes [10], and can depend strongly on the 5’ and 3’ flanking base as shown in mutational signatures for several mutational processes [11].”
BackgroundGeorgakopoulos‐Soares, I., Koh, C. C., Momen, S., Jiricny, J., Hemberg, M., & Nik‐Zainal, S. (2020) · Nature Communications · doi:10.1038/s41467-020-15901-w · Cited by 32
Applications of Genome-Wide Screening and Systems Biology Approaches in Drug Repositioning
Mohammadi, E., Benfeitas, R., Türkez, H., Borén, J., Nielsen, J., Uhlén, M., & Mardinoğlu, A. (2020) · Cancers · doi:10.3390/cancers12092694 · Cited by 30
“org/ [37] TDR Genomics https://tdrtargets.”
Somatic mutation load and spectra: A record of DNA damage and repair in healthy human cells
Saini, N., & Gordenin, D. A. (2018) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22215 · Cited by 28
Three-dimensional genome: developmental technologies and applications in precision medicine
Li, Y., Tao, T., Du, L., & Zhu, X. M. (2020) · Journal of Human Genetics · doi:10.1038/s10038-020-0737-7 · Cited by 25
“Mutations produce a large number of oncogenes [74] coupled with changes in chromatin and TAD, which will form different combinations of enhancers and cancer genes,”
BackgroundHistone modifiers: Dynamic regulators of the cutaneous transcriptome
Ghosh, K., O’Neil, K., & Capell, B. C. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.12.006 · Cited by 28
“Remarkably, by regulating the accessibility of the genome to DNA repair factors, histone modifications are the most influential factor in determining both the location and density of genetic mutations in cancers[38, 39].”
BackgroundReduced intrinsic DNA curvature leads to increased mutation rate
Duan, C., Huan, Q., Chen, X., Wu, S., Carey, L. B., He, X., & Qian, W. (2018) · Genome biology · doi:10.1186/s13059-018-1525-y · Cited by 26
Mas-Ponte, D., McCullough, M., & Supek, F. (2022) · Clinical Science · doi:10.1042/cs20210682 · Cited by 26
A half century of exploring DNA excision repair in chromatin
Smerdon, M. J., Wyrick, J. J., & Delaney, S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105118 · Cited by 25
“Moreover, a significant correlation exists between mutation density and chromatin accessibility in melanocytes (161).”
BackgroundGregoire, J.-M., Fleury, L., Salazar-Cardozo, C., Alby, F., Masson, V., Arimondo, P. B., & Ausseil, F. (2016) · BMC Cancer · doi:10.1186/s12885-016-2683-5 · Cited by 25
“Higher-order chromatin structure is also an important regulator of gene expression during mammalian development, lineage specification [13] and shapes the mutational landscape of cancer [14].”
Carcinoma of unknown primary (CUP): an update for histopathologists
Beauchamp, K., Moran, B., O'Brien, T. N., Brennan, D. J., Crown, J. P., Sheahan, K. D., & Cotter, M. B. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10101-6 · Cited by 22
“The theoretical framework of all methods rely on the same fundamental principle: chromatin accessibility broadly defines cell states [52].”
MethodSeifert, M., Friedrich, B., & Beyer, A. (2016) · Genome biology · doi:10.1186/s13059-016-1058-1 · Cited by 24
A computationally fast variable importance test for random forests for high-dimensional data
Janitza, S., Celik, E., & Boulesteix, A. (2016) · Advances in Data Analysis and Classification · doi:10.1007/s11634-016-0270-x · Cited by 38
Modeling double strand break susceptibility to interrogate structural variation in cancer
Ballinger, T. J., Bouwman, B. A. M., Mirzazadeh, R., Garnerone, S., Crosetto, N., & Semple, C. A. M. (2019) · Genome biology · doi:10.1186/s13059-019-1635-1 · Cited by 24
Analytical Approaches for ATAC‐seq Data Analysis
Smith, J. P., & Sheffield, N. C. (2020) · Current Protocols in Human Genetics · doi:10.1002/cphg.101 · Cited by 25
“…understanding of the fundamental biology of gene regulation, but also its influence on human health and disease (Chan et al., 2018; Corces et al., 2016; Corces, et al., 2018; Hatzi et al., 2019; Lara-Astiaso et al., 2014; Polak et al., 2015 Fraser, 2016; Tewari et al., 2012; Wang et al., 2018).”
BackgroundGenome-Wide Mapping of UV-Induced DNA Damage with CPD-Seq
Mao, P., & Wyrick, J. J. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0763-3_7 · Cited by 24
Mining mutation contexts across the cancer genome to map tumor site of origin
Chakraborty, S., Martin, A. S., Guan, Z., Begg, C. B., & Shen, R. (2021) · Nature Communications · doi:10.1038/s41467-021-23094-z · Cited by 22
Identifying DNase I hypersensitive sites as driver distal regulatory elements in breast cancer
D’Antonio, M., Weghorn, D., D’Antonio‐Chronowska, A., Coulet, F., Olson, K. M., DeBoever, C., Drees, F., Arias, A. D., Alakus, H., Richardson, A. L., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00100-x · Cited by 23
Self-citationHung, S., Saiakhova, A., Faber, Z. J., Bartels, C. F., Neu, D., Bayles, I., Ojo, E. O., Hong, E. S., Pontius, W., Morton, A. R., et al. (2019) · eLife · doi:10.7554/elife.40760 · Cited by 23
“Second, tumor epigenomes are heterogeneous and mutation rates are profoundly influenced by chromatin states, with euchromatic, early-replicating regions showing a low mutation rate relative to heterochromatic, late-replicating regions (Schuster-Böckler and Lehner, 2012; Polak et al., 2015).”
BackgroundExtrinsic and intrinsic drivers of natural killer cell clonality
Rückert, T., & Romagnani, C. (2024) · Immunological Reviews · doi:10.1111/imr.13324 · Cited by 22
Experimental identification of cancer driver alterations in the era of pan‐cancer genomics
Korenjak, M., & Zavadil, J. (2019) · Cancer Science · doi:10.1111/cas.14210 · Cited by 25
Supervised mutational signatures for obesity and other tissue-specific etiological factors in cancer
Afsari, B., Kuo, A., Zhang, Y., Li, L., Lahouel, K., Danilova, L., Favorov, A. V., Rosenquist, T. A., Grollman, A. P., Kinzler, K. W., et al. (2021) · eLife · doi:10.7554/elife.61082 · Cited by 21
Tissue Specific DNA Repair Outcomes Shape the Landscape of Genome Editing
Meyenberg, M., da Silva, J. F., & Loizou, J. I. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.728520 · Cited by 23
Preferential Protection of Genetic Fidelity within Open Chromatin by the Mismatch Repair Machinery
Sun, L., Zhang, Y., Zhang, Z., Zheng, Y. P., Du, L., & Zhu, B. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.719971 · Cited by 20
“More recently, it has been reported that nucleosome occupancy may impact the accumulation of mutations (18) and that heterochromatic regions tend to accumulate more mutations (15, 17, 19, 20), suggesting that the epigenetic status of different chromatin regions may impact whether a mutation occurs or whether a mutatio…”
BackgroundThompson, J. A., Christensen, B. C., & Marsit, C. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082296 · Cited by 21
Meyerson, W. U., Leisman, J., Navarro, F. C. P., & Gerstein, M. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3508-8 · Cited by 22
The impact of cross-kingdom molecular forensics on genetic privacy
Elhaik, E., Ahsanuddin, S., Robinson, J. M., Foster, E. M., & Mason, C. E. (2021) · Microbiome · doi:10.1186/s40168-021-01076-z · Cited by 22
Niculescu, V. F. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.12.006 · Cited by 21
Insights into the Link between the Organization of DNA Replication and the Mutational Landscape
Gaboriaud, J., & Wu, P.-Y. J. (2019) · Genes · doi:10.3390/genes10040252 · Cited by 23
“Analysis of cancer genomes revealed that increased mutation rates are strongly correlated with closed chromatin, in particular with the heterochromatin-associated H3K9me3 histone modification [33,80].”
BackgroundHarms, P. W., Verhaegen, M. E., Vo, J. N., Tien, J. C.-Y., Pratt, D. W., Su, F., Dhanasekaran, S. M., Cao, X., Mangelberger, D., Goor, J. J. V., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.07.173 · Cited by 20
Tumor mutational landscape is a record of the pre-malignant statePreprint
Kübler, K., Karlić, R., Haradhvala, N. J., Ha, K., Kim, J., Kuzman, M., Jiao, W., Gakkhar, S., Mouw, K. W., Braunstein, L. Z., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/517565 · Cited by 21
Self-citationCholangiocarcinoma: Molecular Abnormalities and Cells of Origin
Testa, U., Pelosi, E., & Castelli, G. (2023) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221128689 · Cited by 19
“46 A prediction of the cell-of-origin of biliary tract cancers was performed, as based on the analysis of somatic mutation pro fi les and epigenetic features, showing that 33% of biliary cancers were classi fi ed as hepatic and 38% as epithelial cell types: iCCA samples were more frequently classi fi…”
MethodFuture in the past: paternal reprogramming of offspring phenotype and the epigenetic mechanisms
Wu, D., Zhang, K., Guan, K., Khan, F. A., Pandupuspitasari, N. S., Negara, W., Sun, F., & Huang, C. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03713-6 · Cited by 20
“In addition, the reciprocal inter-regulation between epigenetics and genetics makes epigenetic inheritance has origin of mutations in genes involved in epigenetic regulation (Polak et al. 2015; Lappalainen and Greally 2017; Bailey et al. 2018; Pich et al. 2018).”
Tissue specificity of DNA repair: the CRISPR compass
da Silva, J. F., Meyenberg, M., & Loizou, J. I. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.07.010 · Cited by 18
Guest, R. V., Goeppert, B. F., Nault, J., & Sia, D. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.08.014 · Cited by 20
Differentially Methylated Super-Enhancers Regulate Target Gene Expression in Human Cancer
Flam, E. L., Danilova, L., Kelley, D. Z., Stavrovskaya, E. D., Guo, T. W., Considine, M., Qian, J. X., Califano, J. A., Favorov, A. V., Fertig, E. J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51018-x · Cited by 18
Cheloshkina, K., & Poptsova, M. S. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008749 · Cited by 17
“Conversely, histone markers were shown to be the main contributors in predicting cancer point mutations [5,9].”
BackgroundMethodLee, C. A., Abd-Rabbo, D., & Reimand, J. (2021) · Genome biology · doi:10.1186/s13059-021-02318-x · Cited by 20
Salvadores, M., & Supek, F. (2024) · Nature Cancer · doi:10.1038/s43018-023-00707-8 · Cited by 17
“1,6–8).”
InfluentialEarly TP53 Alterations Shape Gastric and Esophageal Cancer Development
Sahgal, P., Huffman, B. M., Patil, D. T., Chatila, W. K., Yaeger, R. D., Cleary, J. M., & Sethi, N. S. (2021) · Cancers · doi:10.3390/cancers13235915 · Cited by 20
“Furthermore, esophageal adenocarcinomas display chromatin profiles that mirror those found in gastric tissue (H3K9me3, H3K4me1, H3K4me3, H3K9ac, H3K36me3) rather than in normal esophageal tissue [2].”
BackgroundWang, S., Klein, S. O., Urban, S., Staudt, M., Barthes, N. P. F., Willmann, D., Bacher, J., Sum, M., Bauer, H., Peng, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44243-6 · Cited by 17
Negative selection maintains transcription factor binding motifs in human cancer
Vorontsov, I. E., Khimulya, G., Lukianova, E., Nikolaeva, D. D., Eliseeva, I. A., Kulakovskiy, I. V., & Makeev, V. J. (2016) · BMC Genomics · doi:10.1186/s12864-016-2728-9 · Cited by 22
“The DNase accessibility data (breast cancer and lung adenocarcinoma only) were collected for related cell lines and normal tissues [34] (Additional file 5: Table S4).”
BackgroundChromatin organization modulates the origin of heritable structural variations in human genome
Roychowdhury, T., & Abyzov, A. S. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz103 · Cited by 16
Chromatin structure changes during various processes from a DNA sequence view
Quan, H., Yang, Y., Liu, S., Tian, H., Xue, Y., & Gao, Y. Q. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.10.010 · Cited by 16
Perez, S., Lavi-Itzkovitz, A., Gidoni, M., Domovitz, T., Dabour, R., Khurana, I., Davidovich, A., Tobar, A., Livoff, A., Solomonov, E., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.03.004 · Cited by 15
“Furthermore, the epigenetic chromatin organization of the cell-of-origin of a tumor was observed to be the best correlated with its regional variation in mutations rates.(17) Previous studies have supported a correlation between compact chromatin and decreased mutations, either owing to less accessibility to the mutag…”
BackgroundResultDrug Repurposing: Insights into Current Advances and Future Applications
Bhatia, T., & Sharma, S. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673266470231023110841 · Cited by 19
Nakauma‐González, J. A., Rijnders, M., Noordsij, M. T. W., Martens, J. W. M., van der Veldt, A. A. M., Lolkema, M. P., Boormans, J. L., & van de Werken, H. J. G. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100528 · Cited by 17
“Since DNA-accessibility varies per tumor-tissue of origin [54, 55], this was estimated for 502 mUC and mBC using ChIPseq experiments from normal tissue as described above.”
MethodDooley, A. J., Gupta, A., & Middleton, M. R. (2016) · Targeted Oncology · doi:10.1007/s11523-015-0410-9 · Cited by 19
“Melanoma is the most mutated tumour in oncology, suggesting the presence of numerous alternate pathways that could play a role in resistance development [23].”
BackgroundMutSpot: detection of non-coding mutation hotspots in cancer genomes
Guo, Y. A., Chang, M. M., & Skanderup, A. J. (2020) · npj Genomic Medicine · doi:10.1038/s41525-020-0133-4 · Cited by 19
Novel technologies in cfDNA analysis and potential utility in clinic
Li, J., Xu, M., Peng, J., Wang, J., Zhao, Y., Wu, W., & Lan, X. (2021) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2021.06.07 · Cited by 15
“As cancer cells usually have an altered chromatin structure and other genomic and epigenomic abnormalities, the lengths of cancer-driven cfDNA fragments are more variable than those of noncancer cfDNA (71,72).”
BackgroundModeling cancer rearrangement landscapes
Maciejowski, J., & Imielinski, M. B. (2016) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2016.12.005 · Cited by 28
“Correlative analyses of variant topography have linked regional fluctuations in SNV density to replication timing [3,11], post-translational chromatin modification [12,13], transcription factor binding [14 e 16], and tissue-specific chromatin accessibility patterns [17].”
BackgroundLim, B., Mun, J., Kim, S., & Kim, S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3033 · Cited by 16
“In addition, cell-of-origin chromatin features are much stronger determinants of cancer mutation rates than are other variables including gene expression, DNA replication, and nucleotide content, revealing that a tissue-specific epigenomic landscape may shape cell type-specific mutagenesis (1).”
BackgroundMethodInfluentialTiong, K.-L., & Yeang, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-29861-1 · Cited by 22
Dietzen, M., Zhai, H.-R., Lucas, O., Pich, O., Barrington, C., Lu, W.-T., Ward, S., Guo, Y., Hynds, R. E., Zaccaria, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50107-4 · Cited by 20
“7A) 28,29 .”
BackgroundYang, J., Xie, K., Wang, Z., & Li, C. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12912 · Cited by 14
Zhan, Y., Guo, Y., & Lu, Q. (2016) · Cytogenetic and Genome Research · doi:10.1159/000448793 · Cited by 17
“…gene expression in 127 human tissue and cell types from healthy individuals and those with diseases [Dixon et al., 2015; Farh et al., 2015; Gjoneska et al., 2015; Leung et al., 2015; Polak et al., 2015; Roadmap Epigenomics Consortium et al., 2015; Tsankov et al., 2015; Ziller et al., 2015].”
BackgroundMethodLearning the cellular origins across cancers using single-cell chromatin landscapes
Bairakdar, M. D., Lee, W., Giotti, B., Kumar, A., Štancl, P., Wagenblast, E., Hambardzumyan, D., Polak, P. P., Karlić, R., & Tsankov, A. M. (2025) · Nature Communications · doi:10.1038/s41467-025-63957-3 · Cited by 17
“Also, melanoma was predicted to originate from melanocytes and glioblastoma (GBM) from fetal-like brain cell subsets, in agreement with previous bulk predictions 21,25 and expected COOs 40 – 42 .”
InfluentialSelf-citationEpigenetic perturbations in aging stem cells
Krauss, S. R., & de Haan, G. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9645-8 · Cited by 15
“In the Roadmap Epigenomics Project, epigenomic information has now been gathered for 127 cell types from most human tissues (Farh et al. 2015; Gjoneska et al. 2015; Leung et al. 2015; Polak et al. 2015; Roadmap Epigenomics et al. 2015; Ziller et al. 2015).”
BackgroundFrom Mutational Mechanisms in Single Cells to Mutational Patterns in Cancer Genomes
Zhang, C., & Pellman, D. S. (2015) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2015.80.027623 · Cited by 15
“(Polak et al. 2015).”
BackgroundCancer mutational signatures representation by large-scale context embedding
Zhang, Y., Xiao, Y., Yang, M., & Ma, J. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa433 · Cited by 13
Heilbrun, E. E., Merav, M., & Adar, S. (2021) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqab020 · Cited by 15
Coupling between Sequence-Mediated Nucleosome Organization and Genome Evolution
Barbier, J., Vaillant, C., Volff, J., Brunet, F., & Audit, B. (2021) · Genes · doi:10.3390/genes12060851 · Cited by 12
Genome-wide profiles of UV lesion susceptibility, repair, and mutagenic potential in melanoma
Perez, B. S., Wong, K. M., Schwartz, E. K., Herrera, R. E., King, D. A., García-Nieto, P. E., & Morrison, A. J. (2021) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2021.111758 · Cited by 17
Convergent TP53 loss and evolvability in cancer
Mansur, M. B., & Greaves, M. F. (2023) · BMC Ecology and Evolution · doi:10.1186/s12862-023-02146-6 · Cited by 14
“The distinctive cells-of-origin of different cancers also constrains and shapes mutational profiles [34].”
BackgroundRoberts, S. A., Brown, A. J., & Wyrick, J. J. (2019) · BioEssays · doi:10.1002/bies.201800152 · Cited by 14
Chromatin Bottlenecks in Cancer
Sarthy, J. F., Henikoff, S., & Ahmad, K. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.01.003 · Cited by 13
“Bypassing these sensors de fi nes additional sets of recurring oncogenic mutations. sets of mutations observed in many tumors and provides insight into novel therapeutic strategies [7].”
The Sound of Silence: How Silenced Chromatin Orchestrates the Repair of Double-Strand Breaks
Kendek, A., Wensveen, M. R., & Janssen, A. (2021) · Genes · doi:10.3390/genes12091415 · Cited by 18
“Interestingly, H3K9me2/3-enriched regions are associated with high mutation rates [54,55], and increased copy number aberrations [56] in cancer, indicating that these silent regions are particularly vulnerable to faulty DNA damage repair.”
BackgroundEpigenetic and non-coding regulation of alcohol abuse and addiction
Farris, S. P., & Mayfield, R. D. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.08.006 · Cited by 14
“Accessibility of genomic mutations associated with human disease may be determined by the epigenome (Polak et al., 2015), the complete set of epigenetic elements present within the cellular environment across the entire genome.”
BackgroundBagante, F., Spolverato, G., Ruzzenente, A., Luchini, C., Tsilimigras, D. I., Campagnaro, T., Conci, S., Corbo, V., Scarpa, A., Guglielmi, A., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.01.049 · Cited by 12
A genome-wide interactome of DNA-associated proteins in the human liver
Ramaker, R. C., Savic, D., Hardigan, A. A., Newberry, K. M., Cooper, G. M., Myers, R., & Cooper, S. J. (2017) · Genome Research · doi:10.1101/gr.222083.117 · Cited by 13
“Further, epige-nomic features were found to be highly predictive of cancer somaticmutationburdens,andthechromatinlandscapeoftheap-propriate primary tissue greatly outperformed that of matched cancer cell lines (Polak et al. 2015).”
Metadata
- Authors
- Polak, P., Karlić, R., Koren, A., Thurman, R., Sandstrom, R., Lawrence, M. S., Reynolds, A., Rynes, E., Vlahoviček, K., Stamatoyannopoulos, J. A., & Sunyaev, S. R.
- Affiliations
- Broad Institute (US)
- University of Zagreb (HR)
- University of Washington (US)
- Corresponding author
- Stamatoyannopoulos, John A.
- Sunyaev, Shamil R.
- ORCID
- Venue
- Nature
- Published
- 2015-02-18
- Volume
- 518
- Issue
- 7539
- Pages
- 360-364
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4405175
- OpenAlex
- W2086239585
- Cited by
- 557
- References
- 29
- Citations by year
- 2026: 22 · 2025: 31 · 2024: 41 · 2023: 41 · 2022: 46 · 2021: 56 · 2020: 55 · 2019: 62 · 2018: 46 · 2017: 60 · 2016: 65 · 2015: 29
- FWCI
- 22.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- creativecommons.org/licenses/by-nc-sa/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor)
- Locations
- Nature (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (HL53750)
- National Heart, Lung, and Blood Institute (P01HL053750, P01 HL53750)
- National Institute of Mental Health (R01MH101244)
- National Human Genome Research Institute (U54HG007010)
- National Cancer Institute (U54CA143874)
- National Institute of Environmental Health Sciences (U01ES017156)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- cell of origin, chromatin accessibility, chromatin modification, DNA replication timing, somatic mutations, mutation density, tissue of origin prediction, cancer cell lines
- MeSH terms
- Chromatin, Humans, Melanocytes, Melanoma, Mutation, Neoplasms, Organ Specificity, Genome, Human, DNA Replication Timing, Epigenesis, Genetic, Cell Line, Tumor, Epigenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.